Background: In-stent restenosis of bare metal stent (BMS) is one of the major drawback of primary coronary intervention (PCI). Currently there is no ideal treatment for BMS restenosis ... safety and efficacy of stenting…
ntroduction: The aim of this work is to assess the risk factors for restenosis on the antiplatelet therapy background after PCI. Materials: A questionnaire was tested on patients after ... into 2 groups. First group was…
most effective treatment for coronary atherosclerotic heart disease. However, the incidence of restenosis within 6 months after the operation is as high as 30% to 50%, becoming a main cause ... proliferation of vascular…
Background: Inflammation plays a pathogenic role in restenosis after percutaneous transluminal coronary angioplasty. Elevated levels of C-reactive protein are one of the strongest prognostic factors in atherosclerosis…
been established as an effective treatment for coronary artery disease. Restenosis is a recurrence of a significant narrowing in the treated vessel. Although a part of the investigative and research ... funding is…
Objective: Restenosis after Percutaneous Coronary Intervention (PCI) is regarded as the result of a combination of various pathological events. The mechanisms are complex and not completely understood. This study aims…
Balloon angioplasty has shown tremendous improvement in the treatment of atherosclerosis, but arterial renarrowing (restenosis) exists despite the benefits of intravascular devices called stents. Nitric Oxide (NO)…
Introduction: Restenosis after stent implantation is one of the major limitations of percutaneous coronary intervention (PCI). Compared to bare metal stents (BMS), drug-eluting stents (DES) have a reduced incidence…
Japanese patients with Acute Myocardial Infarction (AMI). We sought to examine predictors of binary restenosis and early Stent Occlusion (SO) in these patients. Methods: Among 242 consecutive patients with ... early SO…
Background: In- Stent Restenosis (ISR) is the Achilles heel of angioplasty. AnnexinA5 as an anticoagulant has been shown have anti-inflammatory and anti-atherosclerotic effects. Here we aim to investigating ... mRNA…
stenting. To determine relationship between serum hs-CRP level and in-stent restenosis and 6-month MACE in patients who had underwent PCI and stenting. In this cohort study ... month MACE (major adverse cardiac events)…
Background: Restenosis of the carotid artery is a major complication of carotid endarterectomy (CEA). The purpose of this study was to examine the role of CEA techniques on carotid dimensions ... variation…
Background: In stent restenosis has been a considerable major problem with bare-metal stents (BMS). Pharmacological interventions to decrease Instent restenosis (ISR) could be of clinical relevance. Colchicine is…
percutaneous coronary intervention (PCI) has an important role in the pathogenesis of in-stent restenosis (ISR). Previous studies have addressed that serum amyloid A (SAA), high sensitive C-reactive protein ... patients…
advent of the drug-eluting stent, the incidence of in-stent restenosis remains unacceptably high. Gene therapeutic strategies, including catheter-based gene delivery and gene-eluting stents, offer novel treatment…
loss are prominent features of cardiovascular disease. Endothelial damage is a critical trigger of restenosis after percutaneous coronary angioplasty or stent implantation. Consequently, rapid re-endothelialization is…
drug coated balloon (DCB) has achieved significant results in the treatment of in-stent restenosis (ISR) and the last guidelines for myocardial revascularization suggest ... whether drug coated balloon as an efficacy…
Left main coronary artery instent restenosis can be treated by repeat percutaneous intervention with drug-eluting stent. We report a 53- year old patient with protected left main disease ... presented with recurrent…
Stent Restenosis (ISR), a common long-term complication following Vertebral Artery Ostium (VAO) stenting angioplasty often results in recurrent ischemic stroke. There is currently no standard strategy for management
Background: We report the case of a stent under-expansion and In-Stent Restenosis (ISR) due to a severely calcified lesion at the mid Right Coronary Artery (RCA) treated with
aimed to investigate the curative effect of Yiqi Huoxue Tongmai decoction on In-Stent Restenosis (ISR) after Percutaneous Coronary Intervention (PCI) in Coronary Heart Disease (CHD). 95 cases of patients
cystatin C as a possible biomarker of acute ischemia. Background: The incidence of coronary restenosis after stent placement is high, especially in the 1-year follow-up. Inflammation plays ... important role in the…
alternative for treating the stenosis of cardiac and cerebral arteries. However, postoperative In-Stent-Restenosis (ISR) remains a challenge for medical sciences and biomechanical engineering. ISR is related not only
Randomized Controlled Trials (RCTs) comparing TAT and DAT for patients with high risk of restenosis (defined as obesity, diabetes, and long and/or multivessel coronary lesions) were included. Five RCTs ... stent…
been recently reported that inflammatory mechanisms play an important role in in-stent restenosis (ISR) processes. Inflammatory factors after percutaneous coronary intervention (PCI) for dynamic monitoring can probably…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.